Faculty

Denise Boudreau

Affiliate Professor, Epidemiology
Affiliate Professor, Pharmacy

206-287-2067
denise.m.boudreau@gmail.com

Education

PhD Pharmacoepidemiology, University of Washington, 2002
MS Pharmacy Administration, University of Rhode Island, 1996
BS Pharmacy, University of Rhode Island, 1992

Contact

206-287-2067
denise.m.boudreau@gmail.com

1730 Minor Ave, Suite 1600
Seattle, WA 98101

Bio

Dr. Boudreau is a Senior Investigator at the Group Health Research Institute as well as an affiliate faculty member in both the Department of Epidemiology and Pharmacy at the University of Washington. She is involved in a wide array of pharmacoepidemiology and pharmacoeconomic research projects at Group Health and across the HMO Research Network (HMORN). She has extensive experience working with automated health plan data and bring expertise in the areas of observational study design/comparative effectiveness, managed care, drug safety, and economic evaluation. She has been the HMORN Steering Committee Representative on the FDA Mini Sentinel Initiative since 2009. Her main research interests include cancer pharmacoepidemiology, opioid safety, bone health, and cost of cancer.

Research Areas

Research Interests

Pharmacoepidemiology and pharmacoeconomics

Recent Publications (PubMed)

Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems.
(2022 Dec 29)
BMC Health Serv Res 22(1): 1593
Wartko PD, Qiu H, Idu AE, Yu O, McCormack J, Matthews AG, Bobb JF, Saxon AJ, Campbell CI, Liu D, Braciszewski JM, Murphy SM, Burganowski RP, Murphy MT, Horigian VE, Hamilton LK, Lee AK, Boudreau DM, Bradley KA

Provider knowledge, beliefs, and self-efficacy to deprescribe opioids and sedative-hypnotics.
(2022 Dec 22)
J Am Geriatr Soc
Gray SL, Fornaro R, Turner J, Boudreau DM, Wellman R, Tannenbaum C, Marcum ZA, Balderson B, Cook A, Jacobsen AL, Phelan EA

Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder.
(2022 Dec 1)
Psychiatr Serv 73(12): 1330-1337
Braciszewski JM, Idu AE, Yarborough BJH, Stumbo SP, Bobb JF, Bradley KA, Rossom RC, Murphy MT, Binswanger IA, Campbell CI, Glass JE, Matson TE, Lapham GT, Loree AM, Barbosa-Leiker C, Hatch MA, Tsui JI, Arnsten JH, Stotts A, Horigian V, Hutcheson R, Bart G, Saxon AJ, Thakral M, Ling Grant D, Pflugeisen CM, Usaga I, Madziwa LT, Silva A, Boudreau DM

Safety of opioid prescribing among older cancer survivors.
(2022 Feb 1)
Cancer 128(3): 570-578
Salz T, Mishra A, Gennarelli RL, Lipitz-Snyderman A, Moryl N, Tringale KR, Boudreau DM, Kriplani A, Jinna S, Korenstein D

Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
(2021 Jul 7)
Addict Sci Clin Pract 16(1): 46
Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA, PROUD Collaborative

Show complete publication list

In the News

No news articles at this time.